High-Yield Deep-Dive • Head & Neck
FRCS (ORL-HNS) + ABOHNS + EBEORL-HNS relevant
Oral cavity SCC: the ulcer that won’t heal for ENT boards.
A persistent oral ulcer is not a throwaway finding. The safe board approach is to localise the subsite, recognise red flags, prove the diagnosis with tissue, map the primary and neck, and plan function-preserving treatment.
Exam line: “No tissue = no diagnosis. No neck exam = incomplete staging.”

The 60-second overview: how to think through oral cavity SCC
For a board stem, oral cavity SCC is usually tested as a sequence rather than a single fact.
1. Localise
- Oral cavity subsite versus oropharynx.
- Anterior oral tongue and floor of mouth are common danger zones.
- Subsite changes staging, nodal risk and treatment planning.
2. Prove and map
- Persistent ulcer, lump or red-white lesion needs a tissue diagnosis.
- Biopsy the viable edge, not the necrotic centre.
- Image the primary and assess the neck.
3. Treat the whole problem
- Resect the primary where appropriate.
- Manage the neck.
- Rebuild function and plan adjuvant therapy around pathology.
Step 1: localise the lesion before you stage it
The first board trap is confusing oral cavity cancer with adjacent oropharyngeal disease. The pathway changes once the lesion is in tonsil, base of tongue or soft palate territory.
| Oral cavity SCC sites | Not oral cavity in the usual board framing |
|---|---|
| Lip mucosa, anterior two-thirds tongue, floor of mouth, buccal mucosa. | Tonsil and base of tongue belong to the oropharynx pathway. |
| Gingivae/alveolar ridges, retromolar trigone, hard palate. | Soft palate and posterior pharyngeal/oropharyngeal disease change staging and treatment logic. |
| Lower lip can carry sun-exposure risk, especially at the vermilion/lip interface. | HPV-driven oropharyngeal disease should not be managed as oral cavity SCC. |
- Tobacco and alcohol exposure.
- Betel/areca nut exposure where relevant.
- Sun exposure for lower-lip lesions.
- Prior dysplasia or potentially malignant oral disorder.

Red flags: persistence and feel matter more than pain
Pain is not required. A painless, indurated, persistent ulcer can still be malignant until proven otherwise.

| Finding | Board interpretation | Safer next step mindset |
|---|---|---|
| Ulcer, lump or non-healing lesion lasting more than 3 weeks | Do not reassure based on duration alone. | Urgent assessment/referral pathway and tissue diagnosis if suspicious. |
| Induration, everted edge, contact bleeding or numbness | “Malignant feel” in the stem. | Biopsy/referral rather than empirical treatment only. |
| Ventral/lateral tongue, floor of mouth, retromolar trigone or lower lip | Danger subsites for oral cavity malignancy questions. | Lower threshold for biopsy and neck assessment. |
| Firm persistent level I/II node | Possible regional metastatic disease. | Examine the neck, image, and sample suspicious nodes. |
Workup: prove it, then map it
The workup is not “look and treat”. For suspected oral cavity SCC, the board sequence is examination, tissue diagnosis, staging imaging and MDT planning.
- Inspect every oral cavity subsite.
- Palpate the ulcer edge and the floor of mouth bimanually.
- Document lesion size, depth suspicion, fixation and dental/mandibular involvement.
- Examine neck levels I–V.
| Step | Board wording |
|---|---|
| Biopsy | Incisional or punch biopsy from the edge of the lesion; avoid necrotic centre when possible. |
| Primary imaging | MRI or contrast CT to define local extent, bone involvement and surgical planning. |
| Neck assessment | Ultrasound-guided FNA or image-guided sampling for suspicious nodes. |
| Chest / distant disease | Chest imaging or PET/CT depending on stage, smoking risk and local protocol. |
| MDT | Coordinate surgical, pathology, radiotherapy, oncology, dental, dietetic, speech/swallow and reconstruction inputs. |

Board staging pearls: size is not enough
Oral cavity SCC staging and adjuvant decisions are pathology-heavy. For exams, memorise what changes the conversation.

| Pearl | Why it matters |
|---|---|
| DOI ≠ thickness | Depth of invasion drives T stage and correlates with occult nodal risk. Do not substitute surface thickness for DOI. |
| Oral tongue/floor of mouth: think neck | Levels I–III are common first-echelon basins; midline disease can drain bilaterally. |
| ENE is adverse | Extranodal extension changes nodal staging and typically escalates adjuvant treatment discussion. |
| Pathology closes the loop | Positive margin, PNI, LVI, bone invasion and grade are classic “adverse feature” terms. |
Management overview: resect the primary, manage the neck, rebuild function
Oral cavity SCC is commonly surgery-first when resectable, but the final plan depends on stage, subsite, nodal status, patient factors and pathology.
Early oral cavity SCC
- Wide local excision or subsite-specific resection.
- Margin-driven surgery.
- Sentinel node biopsy or elective neck treatment where indicated.
Advanced / node-positive
- Primary resection plus neck dissection.
- Reconstruction to restore form and function.
- Adjuvant radiotherapy ± systemic therapy based on risk.
| Supportive care domain | Why boards care |
|---|---|
| Dental | Especially important before radiotherapy and for long-term oral health. |
| Nutrition | Malnutrition and treatment-related dysphagia can interrupt therapy and recovery. |
| Speech and swallow | Oral cavity treatment affects articulation, mastication and deglutition. |
| Smoking cessation | Part of risk reduction, survivorship and treatment optimisation. |

Common board traps in oral cavity SCC
Most wrong answers are either too passive or skip the neck.
| Trap | Better answer |
|---|---|
| “It has been treated with mouthwash; review only.” | Persistence, induration or high-risk morphology should prompt urgent specialist assessment and biopsy. |
| “The lesion is small, so the neck is irrelevant.” | Depth of invasion and subsite can make the clinically N0 neck clinically important. |
| “Thickness and DOI are the same.” | DOI is measured from the reconstructed basement membrane to deepest invasion and is used for oral cavity T staging. |
| “The oral tongue is oropharynx.” | Anterior two-thirds is oral cavity; base of tongue is oropharynx. |
| “Pain is required for cancer.” | Pain may be absent; painless persistent ulcers can be malignant. |
See the carousel packaged with this article
This article expands on the six-image OtoPrep carousel covering localisation, red flags, biopsy/workup, DOI and neck staging, and management overview.






Practise this in exam format
Turn the recognition pattern into marks with board-style stems, timed sets and analytics across head and neck, rhinology, otology, laryngology and paediatric ENT.
Also available: FRCS free trial · EBEORL-HNS free trial · ENT subscriptions
FAQ: oral cavity SCC
What oral ulcer duration is a red flag?
For board purposes, an unexplained oral ulcer lasting more than 3 weeks is a red flag and should not be dismissed, especially if it is indurated, everted, bleeding or in a high-risk site.
What is the key diagnostic step in suspected oral cavity SCC?
Histology. Examination and imaging map the disease, but tissue diagnosis is required before definitive treatment planning.
Why is depth of invasion important?
Depth of invasion is used with tumour size in oral cavity T staging and is also a practical trigger for thinking about occult neck risk.
Which neck levels are most important for oral cavity SCC?
Levels I–III are common first-echelon basins. Midline oral tongue or floor-of-mouth lesions can drain bilaterally, so laterality matters.
What pathology features commonly drive adjuvant treatment discussion?
Positive or close margins, extranodal extension, perineural invasion, lymphovascular invasion, bone invasion and other adverse features commonly influence adjuvant radiotherapy or chemoradiotherapy discussions.
Selected references and further reading
References are included to support medical accuracy and trust for a health-education page.
- NCI PDQ: Lip and Oral Cavity Cancer Treatment — Health Professional Version — oral cavity anatomy, staging, DOI, nodal disease and treatment overview.
- NICE NG12 via NCBI Bookshelf: Suspected cancer recognition and referral — oral ulceration >3 weeks, neck lump and red/red-white oral patches.
- GOV.UK: Delivering Better Oral Health, Chapter 6: Oral cancer — risk factors, prevention and recognition prompts.
- College of American Pathologists: Lip and Oral Cavity Cancer Protocol — pathology reporting fields including DOI, margins, LVI, nodal levels and ENE.
- NCBI Bookshelf: Oral Management of Patients Undergoing Radiation Therapy — dental and oral complications before, during and after head-and-neck radiotherapy.
- Royal College of Surgeons/FDS: Oral and dental management before, during and after cancer therapy — multidisciplinary dental assessment and supportive care guidance.
Keep learning
Useful next clicks for mocks, trials and structured ENT revision.
Educational content only. This page is designed for ENT examination preparation and should not be used as individual medical advice. Follow local guidelines and specialist input for real patients.